Atlas Trials

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

Clinical trial NCT07549503 · RECRUITING

Trial details

NCT number
NCT07549503
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Transplant
Start date
2026-05-14
Primary completion
2031-04-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.